Direct purchaser, end payor plaintiffs get partial class certification in US antitrust litigation over HIV medication
MLex Summary: Direct purchaser and end payor plaintiffs suing Gilead Sciences and others over an alleged scheme to monopolize the supply of HIV treatments have won partial class certification in California...To view the full article, register now.
Already a subscriber? Click here to view full article